Cargando…

Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction

The presence of disease-specific antigens and autoantibodies in the sera of patients with atherosclerosis-related diseases has been widely reported and is considered to result from inflammation of the arterial wall and the involvement of immune factors. The aim of this study was to identify a novel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kubota, Masaaki, Yoshida, Yoichi, Kobayashi, Eiichi, Matsutani, Tomoo, Li, Shu-Yang, Zhang, Bo-Shi, Mine, Seiichiro, Machida, Toshio, Takizawa, Hirotaka, Hiwasa, Takaki, Iwadate, Yasuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571331/ https://www.ncbi.nlm.nih.gov/pubmed/34741085 http://dx.doi.org/10.1038/s41598-021-01176-8

Ejemplares similares

Elevation of Autoantibody in Patients with Ischemic Stroke
por: YOSHIDA, Yoichi, et al.
Publicado: (2018)

Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease
por: Kubota, Masaaki, et al.
Publicado: (2022)

Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction
por: Wang, Hao, et al.
Publicado: (2021)

Association between serum anti-ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension
por: Li, Shu-Yang, et al.
Publicado: (2020)

Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus
por: Namiki, Toshiki, et al.
Publicado: (2023)

GADD34 activates p53 and may have utility as a marker of atherosclerosis
por: Tomiyoshi, Go, et al.
Publicado: (2023)

Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma
por: Yoshioka, Masaki, et al.
Publicado: (2018)

Two Patients with Reversible Cerebral Vasoconstriction after Carotid Artery Stenting
por: Yoshida, Yoichi, et al.
Publicado: (2021)

Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
por: Li, Shu-Yang, et al.
Publicado: (2023)

Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX)
por: Machida, Toshio, et al.
Publicado: (2015)

Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
por: Li, Shu-Yang, et al.
Publicado: (2021)

Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction
por: Wang, Hao, et al.
Publicado: (2017)

Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases
por: Yoshida, Yoichi, et al.
Publicado: (2020)

Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas
por: Matsutani, Tomoo, et al.
Publicado: (2012)

NQPC-05 BEVACIZUMAB AFTER PROGRESSION OF GLIOBLASTOMA PROLONGS PATIENT’S LIVING TIME AT HOME IN THE LAST 90 DAYS
por: Matsutani, Tomoo, et al.
Publicado: (2019)

STMO-05 SURGICAL AND FUNCTIONAL OUTCOME OF AWAKE SURGERY FOR INSULAR GLIOMA
por: Hirono, Seiichiro, et al.
Publicado: (2019)

MPC-8 Serum anti-zinc finger FYVE domain-containing protein 21 (ZFYVE21) autoantibody as a novel biomarker for oligodendroglioma IDH-mutant and 1p/19q co-deletion
por: Matsutani, Tomoo, et al.
Publicado: (2021)

Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas
por: Adachi-Hayama, Masayo, et al.
Publicado: (2014)

Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack
por: Yoshida, Yoichi, et al.
Publicado: (2017)

Serum anti‐LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases
por: Sumazaki, Makoto, et al.
Publicado: (2020)

STMO-11 Supratotal resection of Glioblastoma with Methionine PET
por: Ko, Ozaki, et al.
Publicado: (2020)

Ruptured bilateral middle cerebral artery aneurysms diagnosed based on cerebral vasospasm-associated ischemic symptoms: A case report
por: Yoshida, Yoichi, et al.
Publicado: (2022)

Carotid Artery Stenting for Patients with Radiation-Induced Carotid Artery Stenosis
por: Yoshida, Yoichi, et al.
Publicado: (2022)

STMO-13 PATHOLOGICAL EVALUATION AND ONCOLOGICAL OUTCOME OF FLAIRECTOMY IN PATIENTS WITH IDH1 WILD-TYPE GLIOBLASTOMA
por: Hirono, Seiichiro, et al.
Publicado: (2022)

Mechanical Thrombectomy for Acute Ischemic Stroke Complicated by Bacterial Meningitis and Infective Endocarditis
por: Kubota, Masaaki, et al.
Publicado: (2020)

STMO-3 Mid- to long-term outcome of supratotal resection of IDH1 wild-type glioblastoma based on 11C-methionine PET: a retrospective, single-center study
por: Hirono, Seiichiro, et al.
Publicado: (2021)

Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on (11)C-methionine PET: a retrospective, single-center study
por: Hirono, Seiichiro, et al.
Publicado: (2021)

Role of Evaluating MGMT Status and 1p36 Deletion in Radiosurgery-Induced Anaplastic Ependymoma That Rapidly and Completely Resolved by Temozolomide Alone: Case Report and Review of the Literature
por: Hirono, Seiichiro, et al.
Publicado: (2015)

Correlation between Higher Brain Dysfunction and Cerebral Blood Flow after Carotid Artery Stenting
por: Orimoto, Ryousuke, et al.
Publicado: (2021)

GCT-09. HEALTH AND SOCIAL ISSUES IN THE LONG-TERM GERM-CELL TUMOR SURVIVORS
por: Matsutani, Tomoo, et al.
Publicado: (2020)

The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
por: Ito, Masaaki, et al.
Publicado: (2023)

Elevated Adiponectin Antibody Levels in Sera of Patients with Atherosclerosis-Related Coronary Artery Disease, Cerebral Infarction and Diabetes Mellitus
por: Hiwasa, Takaki, et al.
Publicado: (2016)

PATH-03. HIGH-GRADE NEUROEPITHELIAL TUMOR SHOWING BCOR IMMUNOPOSITIVITY WITHOUT EXON 15 INTERNAL TANDEM DUPLICATIONS IN A FIVE-YEAR-OLD BOY: A CASE REPORT
por: Wakita, Shogo, et al.
Publicado: (2020)

CS-1 Cerebellar liponeurocytoma; Report of two cases with detailed metabolic, immunohistochemical, and genetic evaluations
por: Shimizu, Miyuki, et al.
Publicado: (2021)

Molecular imaging of 1p/19q deletion in oligodendroglial tumours with (11)C-methionine positron emission tomography
por: Iwadate, Yasuo, et al.
Publicado: (2016)

In-stent stenosis after stenting the PulseRider for a middle cerebral artery aneurysm: A case report
por: Sakata, Marina, et al.
Publicado: (2023)

Circulating Anti-Sorting Nexins 16 Antibodies as an Emerging Biomarker of Coronary Artery Disease in Patients with Obstructive Sleep Apnea
por: Katsumata, Yusuke, et al.
Publicado: (2020)

Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
por: Ito, Masaaki, et al.
Publicado: (2021)

Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke
por: Hiwasa, Takaki, et al.
Publicado: (2021)

CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy
por: Hara, Ayaka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_us80cm9r4j9o2cu5vlj33rqgc1